# COSELA

NDC: 73594-0101
Generic name: trilaciclib
Labeler / Manufacturer: Pharmacosmos Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250825

FDA application: NDA214200

## Active ingredients

- TRILACICLIB DIHYDROCHLORIDE: 300 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73594-0101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73594-0101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3179c19-78f3-4bf1-b73e-7f7638522ab1